Muhammad Rafiq

Mr. Muhammad Rafiq

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2023 in Genes
Verified
Journal Article
Open access
PDF file
MRMuhammad Rafiq
Muhammad Rafiq
ADAbdullahi Dandare
Abdullahi Dandare
AJArham Javed
Arham Javed
ALAfrose Liaquat
Afrose Liaquat
ARAfraz Ahmad Raja
Afraz Ahmad Raja
ANAisha Naeem
Aisha Naeem
Coronary heart disease (CHD) is a global health concern, and its molecular origin is not fully elucidated. Dysregulation of ncRNAs has been linked to many metabolic and infectious diseases. This study aimed to explore the role of circRNAs in the pathogenesis of CHD and predicted a candidate circRNA that could be targeted for therapeutic approaches to the disease. circRNAs associated with CHD were identified and CHD gene expression profiles were obtained, and analyzed with GEO2R. In addition, differentially expressed miRNA target genes (miR-DEGs) were identified and subjected to functional enrichment analysis. Networks of circRNA/miRNA/mRNA and the miRNA/affected pathways were constructed. Furthermore, a miRNA/mRNA homology study was performed. We identified that hsa_circ_0126672 was strongly associated with the CHD pathology by competing for endogenous RNA (ceRNA) mechanisms. hsa_circ_0126672 characteristically sponges miR-145-5p, miR-186-5p, miR-548c-3p, miR-7-5p, miR-495-3p, miR-203a-3p, and miR-21. Up-regulation of has_circ_0126672 affected various CHD-related cellular functions, such as atherosclerosis, JAK/STAT, and Apelin signaling pathways. Our results also revealed a perfect and stable interaction for the hybrid of miR-145-5p with NOS1 and RPS6KB1. Finally, miR-145-5p had the highest degree of interaction with the validated small molecules. Henchashsa_circ_0126672 and target miRNAs, notably miR-145-5p, could be good candidates for the diagnosis and therapeutic approaches to CHD.

3 June 2023 in Clinica Chimica Acta
Verified
Journal Article
Closed access
MRMuhammad Rafiq
Muhammad Rafiq
ALAfrose Liaquat
Afrose Liaquat
AJArham Javed
Arham Javed
SSSaeed Ullah Shah
Saeed Ullah Shah
RHRashid Hussain
Rashid Hussain
MKMuhammad Jawad Khan
Muhammad Jawad Khan

1 May 2023 in Genes & Diseases
Verified
Journal Article
Open access
ADAbdullahi Dandare
Abdullahi Dandare
ALAfrose Liaquat
Afrose Liaquat
MRMuhammad Rafiq
Muhammad Rafiq
MJMbah Ntepe Leonel Javeres
Mbah Ntepe Leonel Javeres
SYSidra Younis
Sidra Younis
MKMuhammad Jawad Khan
Muhammad Jawad Khan

3 August 2026 in Pharmacology
Verified
Journal Article
Closed access
SZShuxin Zheng
Shuxin Zheng
HDHuaqian Dou
Huaqian Dou
XZXiao Feng Zhang
Xiao Feng Zhang
RCRenshan Chen
Renshan Chen
YWYunjing Wang
Yunjing Wang
XCXiuhui Chen
Xiuhui Chen
Background: Cardiovascular diseases (CVDs) represent a significant global public health challenge. Activation of the NLRP3 inflammasome contributes to CVD pathogenesis, while autophagy mitigates the condition by eliminating harmful metabolites. Summary: Furthermore, NLRP3 inflammasome and autophagy co-regulate CVDs by enhancing autophagic processes, inhibiting inflammasome activity, and reducing inflammatory responses, thus playing a pivotal role in the disease's pathophysiology. Certain pharmacological agents have been shown to inhibit NLRP3 inflammasome activity by promoting autophagy, thereby ameliorating disease pathology. Key Message: This review underscores the pivotal roles of NLRP3 inflammasome and autophagy in CVDs and examines the regulatory effects of specific drugs on these processes.